Navigation Links
Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call
Date:6/12/2008

DAYTON, Ohio, June 12 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that it will release its third quarter fiscal 2008 financial results for the period ended May 31, 2008, before the NYSE opens on Monday, June 30, 2008. A live webcast of the conference call is scheduled for June 30 at 11:00 a.m., EDT with Peter C. Wallace, President and Chief Executive Officer, and Christopher M. Hix, Vice President and Chief Financial Officer. They will discuss the Company's performance and respond to questions from the financial community.

Robbins & Myers invites interested investors to listen to the webcast, which will be broadcast live on its website http://www.robn.com . A webcast replay also will be available at the website and a telephonic replay will be available beginning 1:00 p.m., EDT on June 30, 2008 by dialing +1-888-286-8010 in the U.S. and entering conference ID # 63192398. The international replay number is +1-617-801-6888 with the same ID number.

Robbins & Myers, Inc. is a leading supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical and pharmaceutical markets.


'/>"/>
SOURCE Robbins & Myers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Robbins & Myers Reports Additional Gain and Increases Earnings Guidance
2. Robbins & Myers Schedules Second Quarter Fiscal 2008 Financial Results Conference Call
3. Robbins & Myers to Present at Gabelli Conference
4. Robbins & Myers to Present at Merrill Lynch Growth Industrials Conference December 13, 2007
5. Robbins & Myers Presenting at Bear Stearns 3rd Annual Commodities and Capital Goods Conference November 28, 2007
6. Robbins Bros. Gives Water at AIDS Walk L.A.
7. Robbins & Myers Announces Regular Quarterly Cash Dividend
8. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
9. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
10. Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
11. Bristol-Myers Squibb to Announce Results for the First Quarter of 2008 on April 24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel of ... of proceeds to two local organizations: North Chicago Animal Control and Friends and Our ... a team of authorized and trained volunteers who support rescued animals held in the ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith companies and ... scam operations to a halt. According to Texas Premier Locksmith, these fraudulent locksmith ...
(Date:12/7/2016)... CA (PRWEB) , ... December 07, 2016 , ... The ... the holidays and winter seasons. One major study analyzing heart attacks among 138,602 ... to August of a given year. We would all agree of course–no time of ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen ... Program at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years ... three acupuncturists to help patients realize their family building goals. Acupuncture helps ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- KEY FINDINGS Patient warming and ... loss of blood during surgeries, lowering the risks ... after surgeries, and decreasing risks of SSIs. The ... warming system, surface warming systems, and intravascular warming ... at hospitals thus, lowering the healthcare costs by ...
(Date:12/7/2016)... 7, 2016 Research and Markets has announced ... User - Global Forecast to 2021" report to their offering. ... , , ... by 2021, growing at a CAGR of 7.3% during the forecast period ... prevalence of cancer and rapidly increasing geriatric population across the globe are ...
(Date:12/7/2016)... Dec. 7, 2016 DelveInsight,s, "Janus ... provides in depth insights on the pipeline ... Janus Kinase 3 (JAK3) Inhibitors. The DelveInsight,s ... stages of development including Discovery, Pre-clinical, IND, ... Preregistration. Report covers the product clinical trials ...
Breaking Medicine Technology: